MedicalResearch.com Interview with:
Wayne Winegarden, Ph.D.
Director, Center for Medical Economics and Innovation
Pacific Research Institute
MedicalResearch.com: What is the background for this poll? Would you tell us a little about the Center for Medical Economics and Innovation?
Response: Recent press reports have focused on how extensive innovative gene therapies can be. PRI was interested in learning where Americans stand on these cures of the future, and commission a new national opinion survey to find out.
The Center for Medical Economics and Innovation is a new center launched by PRI this spring to research and advance policies showing how a thriving biomedical and pharmaceutical sector benefits both patients and economic growth. Medical innovation is an important driver of economic growth, responsible for over $1.3 trillion in economic activity each year. As the Milken Institute has found, every job in the biomedical sphere supports another 3.3 jobs elsewhere in the economy.
Among the activities of the Center – which can be accessed at www.medecon.org – are providing free-market analysis to evaluate current policy proposals, producing easy-to-understand data and analysis on current trends in medical science, breaking down complex issues like pharmaceutical and biomedical pricing structures, and demonstrating the benefits that market-based reforms can offer patients and the U.S. health care system.